Steven Ryder

Insider Reports History

Entity
Individual
Location
234 Church Street, Suite 1020, New Haven, CT
Signature
/s/ Richard Bartram, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Ryder:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rallybio Corp Chief Medical Officer Option (Right to Buy) 120K $212K $1.77 Feb 15, 2024 Direct
MBX Biosciences, Inc. Director Stock Option (Right to Buy) 16K Sep 12, 2024 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 Sep 26, 2023 Direct

Insider Reports Filed by Steven Ryder

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MBX MBX Biosciences, Inc. Sep 12, 2024 1 $0 4 Sep 13, 2024 Director
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director
RLYB Rallybio Corp Feb 15, 2024 1 $0 4 Feb 16, 2024 Chief Medical Officer
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 6 $0 4 Sep 26, 2023 Director
RETA REATA PHARMACEUTICALS INC Jun 7, 2023 4 $222K 4 Jun 9, 2023 Director
RLYB Rallybio Corp Feb 6, 2023 1 $0 4 Feb 6, 2023 Chief Medical Officer
RETA REATA PHARMACEUTICALS INC Jul 11, 2022 6 $317K 4 Jul 12, 2022 Director
RETA REATA PHARMACEUTICALS INC Jul 11, 2022 0 $0 3 Jul 11, 2022 Director
RLYB Rallybio Corp Feb 7, 2022 1 $0 4 Feb 9, 2022 Chief Medical Officer
RLYB Rallybio Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 Chief Medical Officer